ChemoSen Cancer Research Results

ChemoSen, chemo-sensitization: Click to Expand ⟱
Source:
Type:
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.

Possible Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-Caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-Ursolic acid
-butein
-Betulinic acid



Scientific Papers found: Click to Expand⟱
4898- Sal,    Salinomycin as a potent anticancer stem cell agent: State of the art and future directions
- Review, Var, NA
CSCs↓, AntiCan↑, ChemoSen↑, RadioS↑, Wnt↓, MAPK↓, TumAuto↑, ATP↓, ROS↑, DNAdam↑, ER Stress↑, CSCsMark↓, Iron↑, *toxicity↝,
4900- Sal,    Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications
- Review, BC, NA
CSCs↓, Apoptosis↑, TumAuto↑, necrosis↑, TumCP↓, TumCI↓, TumCMig↓, TumCG↓, TumMeta↓, eff↑, Bcl-2↓, cMyc↓, Snail↓, ALDH↓, Myc↓, AR↓, ROS↑, NF-kB↓, PTCH1↓, Smo↓, Gli1↓, GLI2↓, Wnt↓, mTOR↓, GSK‐3β↓, cycD1/CCND1↓, survivin↓, P21↑, p27/CDKN1B↑, CHOP/DDIT3↑, Ca+2↑, DNAdam↑, Hif1a↓, VEGF↓, angioG↓, MMP↓, ATP↓, p‑P53↑, γH2AX↑, ChemoSen↑,
4902- Sal,  OXA,    Salinomycin and oxaliplatin synergistically enhances cytotoxic effect on human colorectal cancer cells in vitro and in vivo
- vitro+vivo, CRC, NA
RadioS↑, ChemoSen↑, TumCP↓, Apoptosis↑, ROS↑, MMP↓, MAPK↑, eff↓, TumCG↓, TumCCA↑,
4903- Sal,    Salinomycin: A new paradigm in cancer therapy
- Review, Var, NA
TumCG↓, ATP↓, CSCs↓, ROS↑, Casp↑, MMP↓, selectivity↑, OXPHOS↓, STAT3↓, P53↑, γH2AX↑, cycD1/CCND1↓, TumCCA↑, DNAdam↑, ChemoSen↑,
5003- Sal,    Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review
- Review, Var, NA
CSCs↓, TumAuto↑, selectivity↑, DNAdam↑, TumCCA↑, P-gp/ABCB1↓, Wnt↓, β-catenin/ZEB1↓, RadioS↑, ChemoSen↑, Shh↓, eff↓, ROS↑, AMPK↑, JNK↑, ER Stress↑,
4909- Sal,    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model
- vitro+vivo, CRC, NA
AntiTum↑, Apoptosis↑, mtDam↑, ROS↑, SOD1↓, ChemoSen↑, CSCs↑, ALDH↓, TumCG↓, TumCP↓, TumCD↑, ATP↓,
4910- Sal,    A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
- Review, Var, NA
Apoptosis↑, CSCs↓, ChemoSen↑, RadioS↑, selectivity↑, Wnt↓, toxicity⇅,
5044- SAS,    xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma
- in-vitro, Var, NA
xCT/SLC7A11↓, Ferroptosis↑, ROS↑, IL1↓, IL2↓, NF-kB↓, GSH↓, TumCG↓, ChemoSen↑,
4751- Se,  Chemo,    Selenium Protects Against Toxicity Induced by Anticancer Drugs and Augments Antitumor Activity: A Highly Selective, New, and Novel Approach for the Treatment of Solid Tumors
- in-vivo, Var, NA
Dose↝, ChemoSen↑, chemoP↑,
4725- Se,    Targeting the Nrf2-Prx1 Pathway with Selenium to Enhance the Efficacy and Selectivity of Cancer Therapy
- in-vitro, Lung, A549 - in-vitro, CRC, HT29
AntiCan↑, NRF2↓, Prx↓, ChemoSen↑, *Prx↑, *NRF2↑,
4747- Se,  Chemo,  antiOx,    Phase I trial of selenium plus chemotherapy in gynecologic cancers
- Trial, Ovarian, NA
*toxicity↓, ChemoSen∅, RAD51↓, other↝,
4715- Se,    The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells
- in-vitro, Var, NA
chemoP↑, radioP↑, selectivity↑, ChemoSen↑, GSH↓, *GSH↑, *DNAdam↓, DNAdam↑, eff↑,
4721- SeNPs,    A review on selenium nanoparticles and their biomedical applications
- Review, AD, NA - Review, Diabetic, NA - Review, Arthritis, NA
*antiOx↑, *Inflam↓, *eff↝, *selenoP↑, *Bacteria↓, *neuroP↑, *ROS↓, ChemoSen↑,
4734- SeNPs,  CPT-11,    Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles
- in-vitro, CRC, HCT8 - in-vivo, NA, NA
chemoP↑, ChemoSen↑, P53↑, Apoptosis↑, TumCG↓, Casp↑, Dose↝, NRF2↓, selectivity↑, *NRF2↑,
4745- SeNPs,  Chemo,    Translational Selenium Nanoparticles Promotes Clinical Non-small-cell Lung Cancer Chemotherapy via Activating Selenoprotein-driven Immune Manipulation
- Study, NSCLC, NA
Risk↓, TumCD↑, mTOR↑, AntiTum↑, ChemoSen↑,
4608- SeNPs,    Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
- Review, Var, NA - NA, AD, NA
*toxicity↝, *toxicity↓, *other↝, ROS↑, *Dose↝, *selenoP↑, AntiCan↑, AntiTum↑, *Bacteria↓, *radioP↑, *BioAv↑, *Inflam↓, *Imm↑, ChemoSen↑, *AntiAg↑, selectivity↑, Synergy↑, other↝, *Synergy↑, *Aβ↓, *Synergy↑,
4504- SeNPs,  Chit,  FA,  doxoR,    pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells
- in-vitro, Var, NA
ChemoSen↑, Apoptosis↑, Casp3↑, PARP↝,
4756- SeNPs,    Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy
- in-vitro, Var, NA
ChemoSen↑, RadioS↓,
4469- SeNPs,    Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential
- Review, Var, NA
antiOx↑, selectivity↑, eff↑, AntiCan↑, Apoptosis↑, ROS↑, MMP↓, Casp3↑, Casp9↑, AntiTum↑, TumCG↓, TumMeta↓, angioG↓, Cyt‑c↑, DNAdam↑, RadioS↑, BBB↑, *toxicity↓, ChemoSen↑,
9281- SES, SSM,  LIGs,    A comprehensive review on the anti-cancer properties of sesame lignans: chemical composition, molecular mechanisms and prospects
- Review, Var, NA
Ingr↝, ChemoSen↑, *Sleep↑, *antiOx↑, *GPx↑, *GSR↑, *GSH↑, *MDA↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK2↓, P53↑, COX2/PTGS2↓, TumCP↓, Apoptosis↑, DNAdam↑, cl‑Casp3↑, NF-kB↓, ROS↑, MMP↓, VEGF↓, MMP9↓, Hif1a↓,
9278- SES, SSM,    Antitumor Effects of Sesamin via the LincRNA-p21/STAT3 Axis in Human Bladder Cancer: Inhibition of Metastatic Progression and Enhanced Chemosensitivity
- vitro+vivo, Bladder, UMUC3 - in-vitro, Bladder, 5637
tumCV↓, MMP2↓, STAT3↓, TumCMig↓, TumCI↓, ChemoSen↑, TumVol↓, TumW↓, Ki-67↓, Synergy↑,
3183- SFN,    Sulforaphane potentiates the efficacy of chemoradiotherapy in glioblastoma by selectively targeting thioredoxin reductase 1
- in-vitro, GBM, NA
RadioS↑, TrxR1↓, ROS↑, ChemoSen↑, Prx↓,
2448- SFN,    Sulforaphane and bladder cancer: a potential novel antitumor compound
- Review, Bladder, NA
Apoptosis↑, TumCG↓, TumCI↓, TumMeta↓, glucoNG↓, ChemoSen↑, TumCCA↑, Casp3↑, Casp7↑, cl‑PARP↑, survivin↓, EGFR↓, HER2/EBBR2↓, ATP↓, Glycolysis↓, mt-OXPHOS↓, AKT1↓, HK2↓, Hif1a↓, ROS↑, NRF2↑, EMT↓, COX2/PTGS2↓, MMP2↓, MMP9↓, Zeb1↓, Snail↓, HDAC↓, HATs↓, MMP↓, Cyt‑c↓, Shh↓, Smo↓, Gli1↓, BioAv↝, BioAv↝, Dose↝,
2553- SFN,    Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer
- Review, Bladder, NA
antiOx↓, Inflam↓, ChemoSen↑, ROS⇅, *NRF2↑, *GSH↑, Catalase↑, HO-1↑, NAD↑, chemoP↑,
2556- SFN,    The role of Sulforaphane in cancer chemoprevention and health benefits: a mini-review
- Review, Var, NA
chemoPv↑, HDAC↓, Hif1a↓, angioG↓, CYP1A1↓, ChemoSen↑, BioAv↑,
1458- SFN,    Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma
- Review, Bladder, NA
HDAC↓, eff↓, TumW↓, TumW↓, angioG↓, *toxicity↓, GutMicro↝, AntiCan↑, ROS↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp3↑, Casp9↑, Casp8∅, cl‑PARP↑, TRAIL↑, DR5↑, eff↓, NRF2↑, ER Stress↑, COX2/PTGS2↓, EGFR↓, HER2/EBBR2↓, ChemoSen↑, NF-kB↓, TumCCA?, p‑Akt↓, p‑mTOR↓, p70S6↓, p19↑, P21↑, CD44↓, CSCs↓,
1436- SFN,  PacT,  docx,    Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells
- in-vivo, BC, SUM159
NF-kB↓, ChemoSen↑, IL6↓, IL8↑,
1434- SFN,  GEM,    Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
- in-vitro, CCA, HuCCT1 - in-vitro, CCA, HuH28 - in-vivo, NA, NA
HDAC↓, ac‑H3↑, ChemoSen↑, tumCV↓, TumCP↓, TumCCA↑, Apoptosis↑, cl‑Casp3↑, TumCI↓, VEGF↓, VEGFR2/KDR/Flk1↓, Hif1a↓, eNOS↓, EMT?, TumCG↓, Ki-67↓, TUNEL↑, P21↑, p‑Chk2↑, CDC25↓, BAX↑, *ROS↓, NQO1?,
1474- SFN,    Sulforaphane induces p53‑deficient SW480 cell apoptosis via the ROS‑MAPK signaling pathway
- in-vitro, Colon, SW480
TumCG↓, Apoptosis↑, MMP↓, Bax:Bcl2↑, Casp3↑, Casp7↑, Casp9↑, ROS↑, e-ERK↑, p38↑, P53∅, eff↓, ChemoSen↑,
1509- SFN,    Combination therapy in combating cancer
- Review, Var, NA
NRF2↑, ChemoSideEff↓, eff↑, TumCP↓, Apoptosis↑, TumCCA↑, ChemoSen↑, PSA↓, P53↑, Hif1a↓, CAIX/CA9↓, chemoR↓, 5HT↓,
1494- SFN,  doxoR,    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
- in-vivo, BC, NA - in-vitro, BC, MCF7 - in-vitro, Nor, MCF10
CardioT↓, *GSH↑, *ROS↓, *NRF2↑, NRF2∅, HDAC↓, DNMTs↓, Casp3↑, ER-α36↓, Remission↑, ChemoSen↑, ROS↑, selectivity?,
1484- SFN,    Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action
- Review, Var, NA - Review, AD, NA
neuroP↑, AntiCan↑, NRF2↑, HDAC↓, eff↑, *ROS↓, neuroP↑, HDAC↓, *toxicity∅, BioAv↑, eff↓, cycD1/CCND1↓, CDK4↓, p‑RB1↓, Glycolysis↓, miR-30a-5p↑, TumCCA↑, TumCG↓, TumMeta↓, eff↑, ChemoSen↑, RadioS↑, CardioT↓, angioG↓, Hif1a↓, VEGF↓, *BioAv?, *Half-Life∅,
1481- SFN,  docx,    Combination of Low-Dose Sulforaphane and Docetaxel on Mitochondrial Function and Metabolic Reprogramming in Prostate Cancer Cell Lines
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
ChemoSen↑, Casp3↑, ROS↑, Casp8↑, Cyt‑c↑, Glycolysis↓, GSH↓, GSH/GSSG↓, *toxicity↓,
1731- SFN,    Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts
- Review, Var, NA
CSCs↓, ChemoSen↑, NF-kB↓, Shh↓, Smo↓, Gli1↓, GLI2↓, PI3K↓, Wnt↓, β-catenin/ZEB1↓, Nanog↓, COX2/PTGS2↓, Zeb1↓, Snail↓, ChemoSideEff↓, eff↑, *BioAv↑,
1722- SFN,    Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
- Review, Var, NA
TumCCA↑, CYP1A1↓, CYP3A4↓, Cyt‑c↑, Casp9↑, Apoptosis↑, ROS↑, MAPK↑, P53↑, BAX↑, ChemoSen↑, HDAC↓, GSH↓, HO-1↑,
1730- SFN,    Sulforaphane: An emergent anti-cancer stem cell agent
- Review, Var, NA
BioAv↓, BioAv↑, GSTA1↑, P450↓, TumCCA↑, HDAC↓, P21↑, p27/CDKN1B↑, DNMT1↓, DNMT3A↓, cycD1/CCND1↑, DNAdam↑, BAX↑, Cyt‑c↑, Apoptosis↑, ROS↑, AIF↑, CDK1↑, Casp3↑, Casp8↑, Casp9↑, NRF2↑, NF-kB↓, TNF-α↓, IL1β↓, CSCs↓, CD133↓, CD44↓, ALDH↓, Nanog↓, OCT4↓, hTERT/TERT↓, MMP2↓, EMT↓, ALDH1A1↓, Wnt↓, NOTCH↓, ChemoSen↑, *Ki-67↓, *HDAC3↓, *HDAC↓,
3300- SIL,    Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy
- Review, Var, NA
*ROS↓, *SOD↑, *hepatoP↑, *AST↓, *ALAT↓, *lipid-P↓, *GSH↑, *Catalase↑, *GSTs↑, *GSR↑, *TNF-α↓, *IFN-γ↓, *IL4↓, *IL2↓, *NF-kB↓, *IL10↑, *Inflam↓, COX2/PTGS2↓, Apoptosis↑, ChemoSen↑, PGE2↓, VEGF↓,
3326- SIL,    Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1α/VEGF pathway
- in-vitro, Liver, HepG2 - in-vitro, Liver, Hep3B
*hepatoP↑, chemoPv↑, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, Hif1a↓, VEGF↓, angioG↓,
1316- SIL,  Chemo,    Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
- Analysis, Var, NA
TumCCA↑, p42↓, P450↓, OATPs↓, chemoP↑, ChemoSen↑,
1073- SK,  Chemo,    Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells
- in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
PAK1↓, TumCP↓, Apoptosis↑, ChemoSen↑, ROS↑,
2418- SK,    Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
- in-vitro, HCC, SMMC-7721 cell - in-vitro, HCC, HUH7 - in-vitro, HCC, HepG2
tumCV↓, GlucoseCon↓, lactateProd↓, ChemoSen↑, PKM2↓, Glycolysis↓,
2196- SK,    Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
- Review, Var, NA
*ALAT↓, *AST↓, *Inflam?, *EMT↑, ROS?, TrxR1↓, PERK↑, eIF2α↑, ATF4↑, CHOP/DDIT3↑, IRE1↑, JNK↑, eff↝, DR5↑, Glycolysis↓, PKM2↓, ChemoSen↑, GPx4↓, HO-1↑,
2184- SK,  Cisplatin,    PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
- in-vitro, CRC, T24/HTB-9
PKM2↓, ChemoSen↑, Necroptosis↑,
2182- SK,  Cisplatin,    Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway
- in-vitro, Lung, A549 - in-vitro, Lung, PC9 - in-vivo, NA, NA
tumCV↓, TumCP↓, TumCI↓, TumCMig↓, Apoptosis↑, PKM2↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, ChemoSen↑, TumVol↓, TumW↓, GLUT1↓,
2227- SK,    Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species
- in-vitro, GC, BGC-823 - in-vitro, GC, SGC-7901 - in-vitro, Nor, GES-1
selectivity↑, TumCP↓, TumCD↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, Endon↑, AIF↑, eff↓, ChemoSen↑, TumCCA↑, GSH/GSSG↓, lipid-P↑,
2008- SK,  Cisplatin,    Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
- in-vitro, CRC, HCT116 - in-vivo, NA, NA
ChemoSen↑, selectivity↑, i-ROS↑, DNAdam↑, MMP↓, TumCCA↑, eff↓, *toxicity↓,
5102- SK,  GEM,    Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway
- vitro+vivo, PC, NA
TumCG↓, ChemoSen↑, NF-kB↓, PCNA↓, Ki-67↓, p‑EGFR↓, ROS↑, TumCCA↑, P53↑, JNK↑, Akt↓,
4891- Sper,    Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms
- Review, Var, NA - Review, AD, NA
TumCCA↑, TumCP↓, TumCG↓, *Inflam↓, *antiOx↑, *neuroP↑, *cognitive↑, *Aβ↓, *mitResp↑, AntiCan↑, TumCD↑, TumAuto↑, *AntiAge↑, LC3B-II↑, ATG5↑, Beclin-1/ATG6↑, mt-ROS↑, H2O2↑, Apoptosis↑, *ROS↑, ChemoSen↑, MMP↓, Cyt‑c↑,
1688- SSE,    Potential Role of Selenium in the Treatment of Cancer and Viral Infections
- Review, Var, NA
IL2↑, INF-γ↑, Th1 response↑, Th2↑, Dose↑, AntiCan∅, Risk↑, chemoP↑, Hif1a↓, VEGF↓, selectivity↑, *GADD45A↑, NRF2↓, *NRF2↑, ChemoSen↑, angioG↓, PrxI↓, ChemoSideEff↓, Synergy↑,
1706- SSE,    Selenium in Prostate Cancer: Prevention, Progression, and Treatment
- Review, Pca, NA
Risk∅, ChemoSen↑, Risk↓, toxicity↝, Risk↑, Synergy↑, *toxicity↑, RadioS↑, eff↓, eff↑, ChemoSen↑, ChemoSideEff↓,

Showing Research Papers: 801 to 850 of 903
Prev Page 17 of 19 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 903

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 5,   antiOx↑, 26,   antiOx⇅, 1,   ARE↑, 2,   Bil↝, 1,   Catalase↓, 5,   Catalase↑, 9,   Fenton↑, 11,   frataxin↑, 1,   GCLC↑, 1,   GCLM↑, 1,   GPx↓, 2,   GPx↑, 8,   GPx1↓, 1,   GPx4↓, 18,   GSH↓, 66,   GSH↑, 7,   GSH∅, 1,   GSH/GSSG↓, 5,   GSR↓, 2,   GSR↑, 1,   GSSG↑, 1,   GSTs↓, 2,   GSTs↑, 2,   GSTs↝, 1,   H2O2↓, 1,   H2O2↑, 16,   HO-1↓, 17,   HO-1↑, 19,   HO-2↑, 1,   Iron↓, 1,   Iron↑, 11,   Iron↝, 1,   i-Iron↓, 2,   i-Iron↑, 1,   c-Iron↑, 1,   Keap1↓, 2,   Keap1↑, 2,   lipid-P?, 1,   lipid-P↓, 5,   lipid-P↑, 29,   MDA↓, 4,   MDA↑, 7,   i-MDA↑, 2,   NADH↓, 1,   NADPH/NADP+↓, 1,   NQO1?, 1,   NQO1↓, 3,   NQO1↑, 4,   NRF2↓, 41,   NRF2↑, 39,   NRF2⇅, 1,   NRF2↝, 1,   NRF2∅, 1,   Prx↓, 2,   Prx3↑, 1,   Prx4↑, 1,   Prx6↑, 1,   PrxI↓, 1,   PYCR1↓, 1,   RNS↑, 2,   ROS?, 2,   ROS↓, 38,   ROS↑, 389,   ROS⇅, 11,   ROS↝, 5,   i-ROS↓, 1,   i-ROS↑, 4,   mt-ROS↓, 1,   mt-ROS↑, 8,   RPM↑, 1,   SOD↓, 10,   SOD↑, 11,   SOD1↓, 2,   SOD1↑, 2,   SOD2↓, 2,   SOD2↑, 3,   TBARS↑, 1,   Thiols↓, 2,   Trx↓, 5,   Trx↑, 1,   Trx1↑, 1,   ox-Trx1↑, 1,   TrxR↓, 15,   TrxR↑, 1,   TrxR1↓, 4,   TrxR1⇅, 1,   uricA↓, 1,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 7,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 5,   FTH1↓, 1,   FTL↑, 1,   IronCh↑, 3,   IronCh∅, 1,   NCOA4↑, 2,   STEAP3↑, 1,   Tf↓, 1,   Tf↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   BCR-ABL↓, 1,   CDC2↓, 6,   CDC25↓, 9,   CDC25↑, 1,   compI↓, 5,   compII↓, 1,   compIII↓, 4,   compV↓, 1,   EGF↓, 4,   ETC↓, 5,   ETC↑, 1,   ETC↝, 1,   HSP60/HSPD1↓, 3,   HSP60/HSPD1↑, 1,   Insulin↓, 5,   mitResp↓, 6,   mitResp↑, 1,   Mortalin↓, 1,   mtDam↓, 1,   mtDam↑, 34,   OCR↓, 9,   OCR↑, 2,   OXPHOS↓, 8,   OXPHOS↑, 6,   OXPHOS↝, 1,   mt-OXPHOS↓, 3,   PDH↓, 4,   PDH↝, 1,   PGC-1α↑, 1,   SDH↓, 1,   SDH↑, 1,   SIRT3↓, 2,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX?, 1,   12LOX↓, 2,   5LO↓, 5,   ACC↑, 2,   p‑ACC↑, 1,   ACC-α↓, 2,   ACC1↓, 1,   ACLY↓, 7,   ACSL4↑, 3,   ACSL5↑, 2,   adiP↑, 1,   ADO↓, 1,   ALAT↓, 2,   ALAT↑, 1,   AminoA↓, 1,   AMP↑, 1,   AMPK↓, 1,   AMPK↑, 35,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 37,   ATP↑, 2,   i-ATP↓, 1,   ATP:AMP↓, 1,   CAIX/CA9↓, 4,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   CRM↑, 1,   ECAR↓, 2,   ECAR∅, 1,   ENO1↓, 1,   FABP5/E-FABP↓, 1,   FASN↓, 7,   FASN↑, 2,   FBPase↑, 2,   G6PD↓, 1,   GAPDH↓, 5,   GLS↓, 1,   glucoNG↓, 2,   glucoNG↑, 2,   glucose↓, 2,   glucose↝, 1,   GlucoseCon↓, 21,   GlucoseCon↑, 1,   GlucoseCon∅, 1,   GlutaM↓, 1,   GlutMet↓, 1,   glyC↓, 1,   Glycolysis↓, 61,   Glycolysis↝, 1,   Glycolysis∅, 1,   GSK‐3β↓, 15,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 8,   H2S↑, 1,   Histones↑, 1,   HK1↓, 2,   HK2↓, 32,   HK2∅, 1,   HMG-CoA↓, 4,   KeyT↑, 1,   lactateProd↓, 18,   lactateProd↑, 4,   lactateProd∅, 1,   LDHA↓, 11,   LDHA∅, 1,   LDL↓, 4,   LDL↑, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NAD↑, 1,   NADH:NAD↓, 1,   NADPH↓, 5,   NADPH↑, 2,   PDK1 / PDPK1↓, 9,   PDKs↓, 1,   PFK↓, 6,   PFK1↓, 8,   PFK2?, 1,   PFK2↓, 2,   PFKP↓, 2,   PKM2↓, 25,   PKM2↑, 1,   polyA↓, 1,   Pyrim↓, 1,   Pyruv↓, 3,   SAT1↑, 1,   SCD1↓, 2,   SIRT1↓, 9,   SIRT1↑, 8,   SIRT2↓, 1,   SREBP1/SREBF1↓, 2,   SREBP2↓, 3,   TCA?, 1,   TCA↓, 6,   TCA↑, 2,   TS↓, 5,   Warburg↓, 12,   β-oxidation↓, 2,  

Cell Death(tgid=5) ⓘ

AIF↑, 15,   APAF1↑, 10,   Apoptosis?, 3,   Apoptosis↓, 9,   Apoptosis↑, 337,   Apoptosis∅, 1,   m-Apoptosis↑, 1,   mt-Apoptosis↑, 5,   ASC↓, 1,   BAD↓, 2,   BAD↑, 7,   p‑BAD↓, 1,   Bak↑, 6,   BAX↓, 5,   BAX↑, 127,   BAX⇅, 1,   Bax:Bcl2↑, 32,   Bcl-2↓, 136,   Bcl-2↑, 3,   Bcl-xL↓, 37,   Bcl-xL↑, 2,   BID↓, 3,   BID↑, 3,   p‑BID↓, 1,   BIM↑, 8,   BNIP3↑, 2,   Casp↓, 2,   Casp↑, 54,   Casp↝, 1,   cl‑Casp↑, 1,   Casp1↓, 1,   Casp1↑, 1,   Casp12↑, 1,   Casp2↑, 4,   Casp3↓, 6,   Casp3↑, 165,   cl‑Casp3↑, 29,   proCasp3↑, 1,   pro‑Casp3↑, 1,   CASP4↑, 1,   Casp6↑, 1,   Casp7↓, 1,   Casp7↑, 20,   cl‑Casp7↑, 3,   Casp8↑, 34,   Casp8∅, 1,   cl‑Casp8↑, 8,   Casp9↓, 2,   Casp9↑, 104,   cl‑Casp9↑, 11,   proCasp9↓, 1,   CellShr↑, 1,   cFLIP↓, 4,   Cupro↑, 2,   Cyt‑c↓, 3,   Cyt‑c↑, 97,   mt-Cyt‑c↓, 1,   Diablo↑, 7,   DR5↑, 27,   Endon↑, 1,   FADD↑, 4,   Fap1↓, 1,   Fas?, 1,   Fas↓, 3,   Fas↑, 17,   FasL↓, 2,   FasL↑, 7,   Ferroptosis↑, 39,   GSDME↑, 1,   IAP1↓, 12,   IAP2/BIRC3↓, 6,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 1,   ICD↑, 1,   iNOS↓, 13,   iNOS↑, 1,   Mcl-1↓, 31,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 10,   MDM2↑, 1,   p‑MDM2↓, 2,   MOMP↓, 1,   MOMP↑, 4,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 1,   p38↓, 6,   p38↑, 18,   p‑p38↓, 1,   p‑p38↑, 5,   Paraptosis↑, 3,   pS2/TFF1↓, 1,   PUMA↑, 7,   Pyro↑, 5,   survivin↓, 67,   TRAIL↑, 7,   TRAIL⇅, 1,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 33,   TUNEL↑, 1,   XIAP↓, 32,   XIAP↑, 1,   YAP/TEAD↓, 9,   YAP/TEAD↝, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 182,   Akt↑, 7,   p‑Akt↓, 43,   AKT1↓, 3,   AMPKα↑, 1,   BRAF↓, 1,   CaMKII ↓, 2,   p‑CaMKII ↓, 1,   CIP2A↓, 1,   CK2↓, 5,   cMET↓, 4,   CREB↓, 1,   cSrc↓, 4,   DDIT4↑, 1,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 37,   EGFR↑, 1,   p‑EGFR↓, 3,   ERK↓, 49,   ERK↑, 8,   ERK↝, 1,   p‑ERK↓, 20,   p‑ERK↑, 1,   e-ERK↑, 1,   FGFR1↓, 1,   FOXD3↑, 3,   HCAR2↑, 1,   HER2/EBBR2↓, 16,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 9,   p‑IGF-1R↓, 1,   IGFR↓, 2,   IKKα↓, 6,   p‑IKKα↓, 1,   IκB↓, 4,   p‑IκB↓, 1,   JAK↓, 7,   JAK↝, 1,   JAK1↓, 8,   JAK2↓, 23,   JAK3↓, 1,   JNK↓, 8,   JNK↑, 25,   p‑JNK↓, 2,   p‑JNK↑, 4,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 51,   MAPK↑, 19,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 5,   MEK↑, 1,   p‑MEK↓, 1,   MKP1↓, 1,   MKP2↓, 1,   mTOR↓, 108,   mTOR↑, 3,   p‑mTOR↓, 6,   mTORC2↓, 3,   mTORC2↑, 1,   p42↓, 1,   p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   P90RSK↓, 1,   p‑PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 137,   PI3K↑, 4,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/mTOR/ETS2↓, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 2,   PKCδ↓, 9,   p‑PKCδ↓, 1,   PP2A↑, 1,   PTEN↓, 5,   PTEN↑, 38,   p‑PTEN↓, 1,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 12,   RTK-RAS↓, 1,   p‑S6K↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 15,   Src↓, 2,   p‑Src↓, 1,   STAT↓, 3,   STAT3↓, 90,   STAT3↑, 2,   STAT3↝, 2,   p‑STAT3↓, 10,   p‑STAT3↑, 3,   mt-STAT3↓, 1,   STAT5↓, 4,   STAT6↓, 2,   p‑STAT6↓, 1,   TK1↓, 2,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AFAP1-AS1↓, 1,   ATF2↓, 1,   ATF3↓, 1,   ATF4↓, 1,   ATF4↑, 8,   ATF4↝, 1,   CBP↓, 1,   cJun↓, 7,   cJun↑, 2,   cMyc↓, 43,   cMyc↑, 2,   p‑cMyc↑, 1,   DNMT1↓, 9,   DNMT3A↓, 2,   DNMT3B↓, 2,   DNMTs↓, 8,   EZH2↓, 3,   FOXM1↓, 3,   FOXO↑, 2,   FOXO1↓, 4,   FOXO1↑, 2,   FOXO3↓, 7,   FOXO3↑, 6,   p‑FOXO3↓, 2,   FOXO4↓, 1,   FOXO4↑, 2,   GATA3↑, 1,   H3↓, 2,   H3↑, 1,   p‑H3↓, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H4↓, 1,   H4↑, 2,   ac‑H4↑, 1,   HATs↓, 4,   HATs↑, 1,   HDAC↓, 32,   HDAC1↓, 4,   HDAC2↓, 3,   HDAC3↓, 2,   HDAC6↓, 1,   HDAC8↓, 3,   HES1↓, 2,   miR-106b↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-130a↓, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-143↑, 1,   miR-155↓, 2,   miR-192-5p↑, 1,   miR-195↑, 1,   miR-199↓, 1,   miR-19b↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-21↓, 8,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 3,   miR-29b↓, 1,   miR-30a-5p↑, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 8,   miR-384↑, 1,   miR-422a↑, 1,   miR-429↑, 1,   miR-490↑, 1,   miR-545↑, 1,   miR-99↑, 1,   Myc↓, 6,   MYCN↓, 1,   n-MYC↓, 2,   NDRG1↑, 1,   OCT4↓, 16,   other?, 1,   other↓, 7,   other↑, 11,   other↝, 26,   PAX2↓, 1,   PhotoS↑, 3,   SALL4↓, 1,   sonoS↑, 2,   SOX2↓, 10,   SOX4↓, 3,   SOX4↑, 1,   SOX9?, 1,   SOX9↓, 1,   TCF-4↓, 1,   TFE3↑, 1,   TLE1↓, 1,   tumCV?, 1,   tumCV↓, 81,   tumCV↑, 2,   tumCV∅, 1,   YMcells↓, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 22,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 1,   eIF2α↑, 3,   p‑eIF2α↑, 5,   ER Stress↓, 1,   ER Stress↑, 63,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 10,   HSP27↓, 4,   HSP27↝, 1,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 4,   HSP70/HSPA5↝, 1,   HSP72↑, 1,   HSP90↓, 13,   HSPs↓, 1,   HSPs↑, 1,   HTRA↓, 1,   IRE1↑, 4,   PERK↑, 8,   Proteasome?, 1,   Proteasome↓, 1,   UPR↑, 10,   XBP-1↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 7,   ATG7↑, 3,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 17,   Beclin-1/ATG6⇅, 1,   CTSK↓, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↑, 4,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 17,   LC3s↓, 2,   lysoMP↑, 1,   MitoP↓, 1,   p62↓, 8,   p62↑, 6,   p‑p62↑, 1,   SESN2↑, 3,   TumAuto↓, 3,   TumAuto↑, 67,   TumAuto↝, 2,   mt-TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 3,   ATR↑, 1,   BRCA1↓, 4,   BRCA1↑, 1,   p‑BRCA1↑, 1,   BRCA2↓, 2,   BRCA2↑, 1,   DFF45↑, 1,   DNAdam↓, 3,   DNAdam↑, 104,   DNAdam⇅, 1,   DNArepair↓, 5,   DNArepair↑, 3,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   FEN1↓, 1,   HR↓, 1,   hTERT/TERT↓, 13,   Ku70/XRCC6↓, 1,   MGMT↓, 2,   p16↑, 3,   P53?, 1,   P53↓, 6,   P53↑, 110,   P53↝, 1,   P53∅, 1,   p‑P53↑, 5,   PARP↓, 2,   PARP↑, 22,   PARP↝, 1,   cl‑PARP↓, 2,   cl‑PARP↑, 79,   PARP1↓, 1,   PARP1↑, 3,   cl‑PARP1↑, 2,   PCNA↓, 29,   RAD51↓, 2,   SIRT6↓, 3,   SIRT6↑, 1,   Telomerase↓, 14,   TOP1↓, 10,   TOP2↓, 6,   TOP2↑, 3,   TP53↓, 1,   TP53↑, 3,   TRF2↓, 1,   UHRF1↓, 1,   XRCC1↓, 2,   γH2AX↓, 1,   γH2AX↑, 11,   γH2AX↝, 1,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↑, 1,   CC(CDKs/cyclins)↓, 2,   CDK1?, 1,   CDK1↓, 14,   CDK1↑, 4,   p‑CDK1↓, 2,   CDK2↓, 39,   CDK2↑, 5,   p‑CDK2↓, 1,   CDK4↓, 51,   CDK4↑, 3,   p‑CDK4↓, 1,   CDK4/6↓, 1,   CDK6↓, 21,   CDK6↑, 4,   CDK7↓, 1,   CDKN1C/p57↑, 1,   CHK1↓, 2,   CHK1↑, 2,   p‑CHK1↓, 1,   p‑CHK1↑, 1,   Chk2↓, 1,   Chk2↑, 3,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 10,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 27,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 97,   cycD1/CCND1↑, 3,   p‑cycD1/CCND1↓, 1,   CycD3↓, 3,   cycE/CCNE↓, 23,   cycE/CCNE↑, 1,   cycE/CCNE↝, 1,   cycE1↓, 1,   cycF↑, 1,   E2Fs↓, 5,   GADD45A↓, 1,   GADD45A↑, 2,   Ki-67↓, 36,   MAD↓, 1,   mitA↑, 5,   p19↑, 1,   P21?, 2,   P21↓, 4,   P21↑, 85,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 32,   PLK1↓, 1,   pRB↓, 2,   p‑pRB↓, 3,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 6,   Securin↓, 2,   TubPol↓, 1,   TumCCA?, 2,   TumCCA↓, 12,   TumCCA↑, 269,   TumCCA⇅, 1,   WEE1↑, 1,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 11,   ALDH1A1↓, 6,   Axin2↑, 1,   BMI1↓, 1,   CD133↓, 15,   CD24↓, 2,   CD34↓, 2,   cFos↓, 10,   cFos↑, 1,   cMYB↓, 1,   CSCs?, 1,   CSCs↓, 76,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↓, 1,   Diff↑, 9,   EIF4E↓, 3,   EP4/PTGER4↑, 1,   FGF↓, 2,   Gli↓, 1,   Gli1↓, 11,   HH↓, 16,   HH↝, 1,   HMGCR↓, 2,   HMGCR⇅, 1,   IGF-1↓, 16,   IGF-2↓, 1,   IGFBP1↑, 1,   IGFBP3↑, 1,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 36,   Let-7↑, 2,   LRP6↓, 2,   mTORC1↓, 11,   p‑mTORC1↓, 1,   Nanog↓, 16,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 20,   NOTCH↑, 2,   NOTCH1↓, 14,   NOTCH1↑, 1,   NOTCH2↑, 1,   NOTCH3↓, 3,   OGF↑, 1,   OGFr↑, 3,   p300↓, 1,   PTCH1↓, 4,   PTCH2↓, 1,   SAL↑, 1,   SCF↓, 2,   Shh↓, 9,   Smo↓, 6,   Smo∅, 1,   STAT1↓, 1,   TAZ↓, 1,   TumCG?, 1,   TumCG↓, 155,   TumCG↑, 4,   TumCG∅, 2,   TumCP?, 1,   TumCP↓, 224,   TumCP↑, 6,   Wnt↓, 57,   Wnt/(β-catenin)↓, 5,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 11,   ASAP2↓, 1,   ATPase↑, 1,   AXL↓, 1,   BACH1↓, 1,   BACH1↑, 1,   Ca+2↓, 3,   Ca+2↑, 40,   Ca+2↝, 1,   i-Ca+2?, 1,   i-Ca+2↓, 1,   i-Ca+2↑, 1,   cal2↓, 1,   cal2↑, 2,   Cal9↑, 1,   CCN2/CTGF↓, 2,   Cdc42↓, 2,   Chl↑, 1,   i-Chl↑, 1,   Cofilin↓, 1,   COL1↓, 1,   COL4A3↓, 1,   DLC1↑, 1,   E-cadherin↓, 6,   E-cadherin↑, 52,   EMT?, 1,   EMT↓, 101,   EMT↑, 1,   EMT↝, 1,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 21,   p‑FAK↓, 2,   p‑FAK↑, 1,   fascin↓, 1,   Fibronectin↓, 4,   Furin↓, 1,   GLI2↓, 2,   ITGA2↓, 1,   ITGA5↓, 3,   ITGA6↓, 1,   ITGB1↓, 7,   ITGB3↓, 3,   ITGB4↓, 2,   ITGB6↓, 1,   KRAS↓, 4,   LAMs↓, 2,   LEF1↓, 1,   MALAT1↓, 4,   MET↓, 2,   MET↑, 1,   p‑MET↓, 1,   MMP1↓, 7,   MMP13↓, 2,   MMP16↓, 1,   MMP2↓, 95,   MMP2⇅, 1,   MMP3↓, 6,   MMP7↓, 8,   MMP9↓, 121,   MMP9↑, 1,   MMP9⇅, 1,   MMPs↓, 37,   MUC4↓, 3,   N-cadherin↓, 33,   Na+↝, 1,   NEDD9↓, 1,   PAK1↓, 5,   pax↓, 1,   PDGF↓, 4,   Rac1↓, 3,   Rho↓, 5,   ROCK1↓, 6,   Sharpin↓, 1,   Slug↓, 10,   Smad1↓, 1,   Smad1↑, 2,   SMAD2↓, 1,   SMAD3↓, 2,   SMAD3↑, 1,   SMAD4↓, 1,   SMAD4↑, 1,   Snail↓, 30,   STAC2↓, 1,   TET1↑, 1,   TGF-β↓, 21,   TGF-β↑, 4,   TIMP1↓, 3,   TIMP1↑, 14,   TIMP2↓, 3,   TIMP2↑, 9,   TIMP3↑, 1,   TRIB3↑, 3,   TSP-1↑, 2,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 111,   TumCMig↓, 105,   TumCMig↑, 1,   TumMeta?, 1,   TumMeta↓, 111,   TumMeta↑, 9,   TumPF↓, 1,   Twist↓, 15,   Tyro3↓, 1,   uPA↓, 13,   uPAR↓, 2,   Vim↓, 37,   Vim↑, 1,   vinculin↓, 1,   Zeb1↓, 14,   ZEB2↓, 3,   α-SMA↓, 2,   α-tubulin↓, 2,   β-catenin/ZEB1↓, 72,   β-catenin/ZEB1↑, 3,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 153,   angioG↑, 4,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 5,   ECM/TCF↓, 1,   eNOS↓, 3,   eNOS↑, 1,   HIF-1↓, 6,   Hif1a↓, 79,   Hif1a↑, 2,   Hypoxia↓, 2,   LOX1↓, 1,   LymphAG↓, 1,   NO↓, 5,   NO↑, 3,   NO↝, 1,   PHDs↓, 1,   TYMP/ECGF1↓, 1,   VCAM-1↓, 5,   VEGF↓, 127,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 16,  

Barriers & Transport(tgid=15) ⓘ

ABCG1↓, 1,   BBB↓, 1,   BBB↑, 12,   CellMemb↑, 2,   CLDN1↓, 3,   CLDN2↓, 2,   CLDN2↑, 1,   CTR1↑, 2,   EPR↑, 21,   GLUT1↓, 16,   GLUT1↑, 1,   GLUT2↓, 3,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 146,   MMP↑, 2,   MMP↝, 1,   MPT↑, 6,   Na+↝, 1,   OATPs↓, 2,   TRPC1↑, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 3,   TRPV1↝, 1,   TRPV2↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CCR7↓, 2,   CD4+↓, 1,   CD4+↑, 1,   CD44↓, 20,   CD47↓, 1,   CD59↑, 1,   CD8+↑, 6,   p‑cDC2↓, 1,   COX1↓, 2,   COX2/PTGS2↓, 101,   COX2/PTGS2↑, 1,   CR3↝, 1,   CXCL1↓, 1,   CXCL12↓, 2,   CXCL16↓, 1,   CXCL6/GCP-2↓, 1,   CXCR4↓, 13,   DR4↑, 8,   DR6↑, 1,   FOXP3↓, 2,   FOXP3↑, 1,   Gal-3↓, 3,   HCAR1↓, 1,   HCAR2↑, 1,   HLA↑, 1,   HMGB1↓, 6,   ICAM-1↓, 8,   IFN-γ↓, 4,   IFN-γ↑, 2,   Igs↑, 2,   IL1↓, 5,   IL1↑, 2,   IL10↓, 5,   IL10↑, 4,   IL12↓, 2,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 20,   IL1β↑, 1,   IL2↓, 5,   IL2↑, 6,   IL4↓, 4,   IL4↑, 3,   IL6↓, 44,   IL8↓, 11,   IL8↑, 1,   Imm↑, 38,   Imm↝, 6,   INF-γ↑, 1,   Inflam↓, 56,   Inflam↑, 1,   Inflam↝, 1,   LPS↓, 1,   LRIG1↑, 1,   M2 MC↓, 4,   MCP1/CCL2↓, 6,   MCT1↓, 2,   MIP-1β↑, 1,   MIP2↓, 1,   MyD88↑, 1,   NAF1↓, 2,   NF-kB↓, 199,   NF-kB↑, 8,   NF-kB↝, 1,   p‑NF-kB↓, 3,   p‑NF-kB↑, 2,   NK cell↑, 15,   NLRP3↓, 4,   NLRP3↑, 1,   p50↓, 2,   p65↓, 9,   p‑p65↓, 3,   PAF↓, 1,   PD-1↓, 4,   PD-L1↓, 7,   PGE2↓, 27,   PSA↓, 9,   PSA∅, 1,   RAGE↓, 1,   T-Cell↑, 4,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   TCF7/TCF1↓, 1,   Th1 response↑, 2,   Th2↑, 1,   TLR4↓, 4,   TLR4↑, 1,   TNF-α↓, 39,   TNF-α↑, 6,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRAF1↓, 1,   Treg lymp↓, 3,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,   pH↑, 3,   pH↝, 2,   e-pH↓, 1,   e-pH↑, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   PTN↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 16,   ER-α36↓, 4,   ER(estro)↓, 1,   Estro↝, 1,   GR↑, 1,   PPARα↓, 1,   PPARα↑, 1,   PPARγ↓, 3,   PPARγ↑, 9,   PRL↓, 1,   PXR, NR1I2↓, 1,   RANKL↓, 1,   SXR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   BioAv↓, 72,   BioAv↑, 84,   BioAv↝, 20,   BioEnh?, 1,   BioEnh↑, 6,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 6,   ChemoSen↓, 17,   ChemoSen↑, 894,   ChemoSen⇅, 3,   ChemoSen↝, 2,   ChemoSen∅, 7,   CompStab?, 1,   CompStab↓, 4,   CompStab↑, 4,   CompStab↝, 2,   CYP1A1↓, 5,   CYP1A1↑, 3,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP1B1↓, 2,   CYP1B1↑, 2,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 6,   DDS↑, 2,   Dose?, 8,   Dose↓, 5,   Dose↑, 17,   Dose⇅, 1,   Dose↝, 102,   Dose∅, 18,   eff↓, 78,   eff↑, 182,   eff⇅, 1,   eff↝, 22,   eff∅, 3,   GSTA1↓, 1,   GSTA1↑, 2,   GSTM1↑, 1,   GSTP1/GSTπ↓, 2,   GSTZ1↝, 1,   Half-Life↓, 19,   Half-Life↑, 4,   Half-Life↝, 17,   Half-Life∅, 3,   MDR1↓, 21,   MRP↓, 1,   MRP1/ABCC1↓, 9,   MRP1/ABCC1↝, 1,   MRP2↓, 1,   NAT↓, 1,   P-gp/ABCB1↓, 43,   P-gp/ABCB1↑, 1,   P-gp/ABCB1↝, 1,   P450↓, 6,   P450↝, 1,   RadioS?, 1,   RadioS↓, 3,   RadioS↑, 153,   RadioS↝, 1,   selectivity?, 3,   selectivity↑, 160,   selectivity↝, 1,   Synergy↑, 215,   Synergy↝, 1,   TET2↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   AFP↑, 1,   ALAT↓, 2,   ALAT↑, 1,   ALP↓, 2,   AR↓, 16,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 4,   Bil↝, 1,   BloodF↑, 1,   BMD↑, 2,   BRAF↓, 1,   BRCA1↓, 4,   BRCA1↑, 1,   p‑BRCA1↑, 1,   CA125↓, 1,   CEA↓, 2,   CEC↝, 1,   creat↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 37,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 3,   Ferritin↓, 5,   FOXM1↓, 3,   HER2/EBBR2↓, 16,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 13,   IL6↓, 44,   KeyT↑, 1,   KRAS↓, 4,   LDH↓, 8,   LDH↑, 1,   LDH↝, 1,   Myc↓, 6,   NOS2↑, 1,   NSE↓, 1,   PD-L1↓, 7,   Polyps↓, 1,   PSA↓, 9,   PSA∅, 1,   RAGE↓, 1,   RBC↑, 1,   TG/TAG↓, 1,   TP53↓, 1,   TP53↑, 3,   TRIB3↑, 3,   Tumccf↓, 1,   Tumccf↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiCan↓, 3,   AntiCan↑, 96,   AntiCan?, 1,   AntiCan∅, 1,   antiCG↓, 1,   antiD↑, 1,   AntiDiabetic↑, 1,   antiNeop↑, 5,   antiNeop∅, 1,   AntiTum↓, 1,   AntiTum↑, 42,   Appetite↑, 1,   cachexia↓, 5,   cardioP↑, 19,   CardioT↓, 3,   chemoP?, 1,   chemoP↑, 97,   chemoPv↑, 29,   ChemoSideEff↓, 19,   ChemoSideEff∅, 1,   cognitive↑, 2,   fatigue↓, 2,   fatigue∅, 1,   FTO↓, 1,   FTO↑, 1,   hepatoP↑, 16,   hepatoP↝, 1,   hepatoP∅, 1,   kidSt↓, 1,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 12,   NP/CIPN↓, 3,   NP/CIPN↑, 1,   NP/CIPN↝, 1,   ORR↑, 1,   OS↓, 1,   OS↑, 51,   OS∅, 1,   Pain↓, 5,   PFS↓, 1,   PFS↑, 2,   PFS∅, 1,   QoL↑, 28,   QoL∅, 2,   radioP↑, 22,   Remission↑, 6,   RenoP↑, 11,   RenoP∅, 1,   Risk↓, 43,   Risk↑, 2,   Risk∅, 1,   Sleep↑, 2,   toxicity↓, 38,   toxicity↑, 8,   toxicity⇅, 1,   toxicity↝, 24,   toxicity∅, 8,   TumVol↓, 38,   TumVol⇅, 1,   TumW↓, 22,   TumW⇅, 1,   Weight↓, 1,   Weight↑, 4,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiBio↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 5,   GutMicro↑, 12,   GutMicro↝, 1,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 3,   Ingr↝, 7,  
Total Targets: 1282

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 9,   antiOx↑, 110,   ARE↑, 1,   Catalase↑, 42,   Copper↓, 1,   Fenton↓, 3,   GPx↑, 36,   GPx1↑, 3,   GPx4↑, 3,   GSH↓, 1,   GSH↑, 46,   GSR↑, 8,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 16,   H2O2↓, 3,   H2O2↑, 1,   HDL↓, 1,   HDL↑, 3,   HO-1?, 1,   HO-1↓, 2,   HO-1↑, 27,   Iron↓, 2,   Iron↑, 1,   Iron∅, 1,   i-Iron↓, 1,   Keap1↓, 2,   Keap1↝, 1,   lipid-P?, 1,   lipid-P↓, 36,   MDA↓, 29,   MDA↑, 1,   MPO↓, 5,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2?, 1,   NRF2↓, 1,   NRF2↑, 52,   Prx↑, 1,   RNS↓, 5,   ROS?, 4,   ROS↓, 122,   ROS↑, 2,   ROS↝, 1,   ROS∅, 2,   i-ROS↑, 1,   mt-ROS?, 1,   selenoP↑, 3,   SOD↓, 1,   SOD↑, 51,   SOD1↑, 5,   SOD2↑, 3,   TAC↑, 6,   TBARS↓, 2,   Trx↑, 1,   Trx1↑, 1,   VitC↑, 1,   VitE↓, 1,   VitE↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   FPN↑, 1,   IronCh↑, 3,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compII↑, 1,   compIII↑, 1,   DRP1/DNM1L↓, 1,   EGF↓, 1,   Insulin↓, 2,   Insulin↑, 2,   MFN2↑, 1,   mitResp↑, 2,   mtDam↓, 1,   OCR↑, 1,   PGC-1α↑, 1,   PGC-1α↝, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 5,   adiP↑, 1,   ALAT↓, 14,   AMPK↓, 1,   AMPK↑, 7,   ATP↓, 1,   ATP↑, 4,   CRM↑, 1,   cytoP450↓, 1,   FABP4↓, 1,   glucose↓, 9,   GlucoseCon↑, 2,   glyC↓, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   LDL↓, 8,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 2,   NADPH↑, 2,   NH3↓, 1,   SIRT1↑, 4,   SREBF2⇅, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   Apoptosis↓, 9,   BAX↓, 3,   Bcl-2↓, 1,   Bcl-2↑, 4,   Bcl-xL↑, 1,   Casp↓, 1,   Casp12↓, 1,   Casp3↓, 12,   Casp3∅, 1,   Casp9↓, 5,   Cyt‑c↓, 1,   Cyt‑c∅, 1,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 3,   GranB/GZMB↓, 1,   iNOS↓, 7,   p38↓, 4,   p38↑, 1,   p‑p38↓, 1,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 8,   Akt↝, 1,   p‑Akt↓, 1,   p‑Akt↑, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↑, 1,   ERK↓, 1,   ERK↑, 2,   IGF-1R↓, 1,   IKKα↓, 1,   JAK↓, 1,   JAK2↑, 2,   JNK↓, 3,   p‑JNK↓, 4,   MAPK↓, 8,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 3,   mTOR↑, 2,   p‑mTOR↓, 1,   PDGFR-BB↓, 1,   PI3K↓, 2,   PI3K↑, 4,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 1,   PTEN↓, 1,   PTEN↑, 1,   RAS↓, 1,   STAT3↓, 3,   STAT3↑, 3,   STAT3↝, 1,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 5,   ATF2↑, 1,   ATF4↓, 2,   p‑cMyc↑, 1,   FOXO3↑, 1,   HDAC↓, 3,   HDAC↑, 1,   HDAC3↓, 1,   HOTAIR↑, 1,   other?, 1,   other↓, 3,   other↑, 5,   other↝, 5,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 4,   GRP78/BiP↓, 1,   HSP70/HSPA5↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 9,   DNArepair↑, 2,   P53↓, 4,   PARP1↓, 1,   PCNA↓, 3,   Telomerase↓, 1,   TOP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↓, 1,   E2Fs↑, 1,   GADD34↓, 1,   GADD45A↑, 1,   Ki-67↓, 1,   P21↓, 1,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   CEBPA↓, 1,   HH↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↑, 1,   Ki-67↓, 1,   p300↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↓, 2,   AntiAg↑, 10,   AP-1↓, 3,   Ca+2↓, 3,   Ca+2↝, 2,   Cartilage↑, 1,   COL1↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   EMT↑, 1,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP13↓, 1,   MMP2↓, 2,   MMP3↓, 1,   MMP9↓, 2,   MUC1↑, 1,   TGF-β↓, 2,   TGF-β↑, 2,   TGF-β1↓, 1,   TregCell↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   uPA↑, 1,   Vim↓, 1,   α-SMA↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 2,   Hif1a↑, 2,   NO↓, 10,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 13,   EPR↑, 1,   GastroP↑, 2,   GLUT4↑, 1,   H+/K+-ATPase↓, 1,   IBI↑, 3,   memfluid↑, 1,   MMP↓, 1,   MMP↑, 5,   MMP∅, 1,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   VGSC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   CD8+↑, 2,   COX1↓, 4,   COX2/PTGS2↓, 23,   COX2/PTGS2↑, 1,   FOXP3↑, 1,   HMGB1↓, 2,   ICAM-1↓, 2,   IFN-γ↓, 5,   IFN-γ↑, 1,   IL1?, 1,   IL1↓, 1,   IL10↓, 3,   IL10↑, 8,   IL17↓, 5,   IL18↓, 2,   IL1β↓, 22,   IL2↓, 1,   IL23↓, 1,   IL4↓, 3,   IL4↑, 2,   IL6?, 2,   IL6↓, 34,   IL8↓, 3,   Imm↓, 1,   Imm↑, 10,   Imm↝, 1,   Inflam?, 2,   Inflam↓, 125,   Inflam↑, 1,   LPS↓, 2,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 5,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 36,   NF-kB↑, 1,   NLRP3↓, 6,   NLRP3↑, 1,   PGE2↓, 7,   PGE2↑, 1,   RAGE↓, 2,   SOCS-3↓, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR4↓, 4,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 43,   Treg lymp↝, 1,   TRIF↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 11,   BChE↓, 2,   BDNF↓, 1,   BDNF↑, 7,   GABA↑, 3,   MAOA↓, 4,   MAOB↓, 1,   NGF↑, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 1,   Aβ↓, 18,   Aβ42↓, 1,   BACE/β-secretase↓, 3,   tau↓, 4,   p‑tau↓, 2,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,   AHR↓, 1,   BNP↓, 1,   CYP19↓, 1,   Estro↓, 1,   GR↑, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   p‑PPARγ↓, 1,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 44,   BioAv↑, 50,   BioAv⇅, 1,   BioAv↝, 32,   BioEnh↑, 1,   ChemoSen↑, 5,   CompStab↑, 2,   CompStab↝, 2,   Dose?, 1,   Dose↓, 1,   Dose↑, 4,   Dose↝, 22,   eff↑, 18,   eff↝, 1,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 4,   Half-Life↑, 1,   Half-Life↝, 14,   Half-Life∅, 1,   P450↓, 1,   P450↑, 1,   selectivity↑, 3,   Synergy↑, 15,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 14,   ALP↓, 3,   anemia↓, 1,   AST↓, 16,   BG↓, 2,   BloodF↑, 1,   BMD↑, 2,   BP↓, 7,   BUN?, 1,   BUN↓, 1,   CK/CK-MB↓, 1,   creat↓, 4,   CRP↓, 5,   Ferritin↓, 1,   HemoG↑, 1,   HOMA↓, 1,   hs-CRP↓, 2,   IL6?, 2,   IL6↓, 34,   IRes↝, 1,   LDH↓, 4,   LDH↑, 1,   NOS2↓, 2,   RAGE↓, 2,   RBC↑, 1,   SpO2↑, 1,   TC↓, 2,   TG/TAG↓, 1,   TMAO↓, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 4,   AntiAge↑, 6,   antiAll↑, 15,   AntiArt↑, 10,   AntiCan↓, 2,   AntiCan↑, 24,   AntiDiabetic↑, 29,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 4,   cardioP?, 2,   cardioP↑, 47,   cardioP⇅, 1,   CardioT↓, 2,   chemoP↑, 16,   chemoPv↑, 10,   cognitive↓, 1,   cognitive↑, 19,   cough?, 1,   diuretic↑, 1,   hepatoP↓, 1,   hepatoP↑, 47,   Learn↑, 1,   memory?, 1,   memory↑, 16,   motorD↓, 1,   motorD↑, 1,   Mucositis↓, 1,   neuroP↓, 1,   neuroP↑, 69,   Obesity↓, 12,   OS↑, 3,   Pain↓, 5,   QoL↑, 1,   radioP↑, 7,   RenoP↑, 11,   Risk↓, 2,   Sleep↑, 2,   SoreThr?, 1,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 9,   toxicity?, 1,   toxicity↓, 51,   toxicity↑, 4,   toxicity↝, 18,   toxicity∅, 9,   Weight↓, 1,   Weight↑, 1,   Wound Healing↑, 5,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 6,   AntiFungal↑, 3,   AntiP↑, 1,   AntiViral↑, 12,   Bacteria↓, 27,   Diar↓, 2,   GutMicro↑, 20,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 4,   Ingr↝, 9,  
Total Targets: 466

Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
55 Cisplatin
40 Chemotherapy
39 doxorubicin
31 Curcumin
20 Sulforaphane (mainly Broccoli)
20 Magnetic Fields
20 Thymoquinone
18 5-fluorouracil
18 Resveratrol
15 Luteolin
15 Quercetin
13 Apigenin (mainly Parsley)
13 Docetaxel
13 Artemisinin
13 Baicalein
13 Betulinic acid
13 Chrysin
13 Eugenol
13 Lycopene
12 Radiotherapy/Radiation
12 Fisetin
12 Kaempferol
12 Melatonin
12 Morin
11 Propolis -bee glue
11 Capsaicin
11 Paclitaxel/Taxol
11 Gambogic Acid
11 Honokiol
10 Vitamin C (Ascorbic Acid)
10 diet FMD Fasting Mimicking Diet
10 diet Methionine-Restricted Diet
10 Ivermectin
9 Phenethyl isothiocyanate
9 Citric Acid
9 Metformin
9 EGCG (Epigallocatechin Gallate)
9 Flaxseed/Linseed
9 phytic acid, Inositol hexakisphosphate
8 Sorafenib (brand name Nexavar)
8 Silver-NanoParticles
8 Copper and Cu NanoParticles
8 Ashwagandha(Withaferin A)
8 brusatol
8 Boswellia (frankincense)
8 Selenium NanoParticles
8 salinomycin
8 Formononetin
8 Matrine
8 Shikonin
7 Astragalus
7 Berberine
7 Disulfiram
7 Emodin
7 Pterostilbene
7 Selenite (Sodium)
7 Vitamin K2
6 Allicin (mainly Garlic)
6 Selenium
6 Gemcitabine (Gemzar)
6 borneol
6 chitosan
6 Fucoidan
6 Linalool
6 Magnolol
6 methylseleninic acid
6 Piperlongumine
6 Rosmarinic acid
5 2-DeoxyGlucose
5 Anti-oxidants
5 Astaxanthin
5 Atorvastatin
5 Beta-Caryophyllene
5 Isothiocyanates
5 Cinnamon
5 Coenzyme Q10
5 Crocetin
5 Docosahexaenoic Acid
5 diet Short Term Fasting
5 Indole-3-carbinol
5 Hydrogen Gas
5 Hyperthermia
5 Inositol
5 itraconazole
5 VitK3,menadione
5 Urolithin
4 Alpha-Lipoic-Acid
4 Berbamine
4 Caffeic acid
4 Caffeic Acid Phenethyl Ester (CAPE)
4 carboplatin
4 Chlorogenic acid
4 Cucurbitacin
4 Dichloroacetate
4 Oxygen, Hyperbaric
4 Dandelion Root
4 Ellagic acid
4 tamoxifen
4 isoorientin
4 low dose naltrexone
4 mebendazole
4 Bicarbonate(Sodium)
4 Phenylbutyrate
3 3-bromopyruvate
3 Auranofin
3 Allyl isothiocyanate
3 Andrographis
3 Isovitexin
3 beta-glucans
3 immunotherapy
3 Baicalin
3 Benzyl isothiocyanate
3 Brucea javanica
3 Boron
3 Trastuzumab
3 Piperine
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 Celastrol
3 Chlorophyllin
3 Hydroxycinnamic-acid
3 Electrical Pulses
3 Gallic acid
3 Garcinol
3 Ginkgetin
3 Gossypol/AT-101
3 HydroxyCitric Acid
3 Isorhamnetin
3 isoflavones
3 Methylsulfonylmethane
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Oxaliplatin
3 Patchouli Oil (Pogostemon cablin)
3 Phycocyanin
3 Silymarin (Milk Thistle) silibinin
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Anethole/trans-Anethole
2 Dipyridamole
2 Biochanin A
2 Bromelain
2 erastin
2 Bortezomib
2 Carnosic acid
2 capecitabine
2 Thymol-Thymus vulgaris
2 Cat’s Claw
2 Cannabidiol
2 chemodynamic therapy
2 Celecoxib
2 Folic Acid, Vit B9
2 Calorie Restriction Mimetics
2 Carvone
2 Cynaropicrin
2 Diclofenac
2 Diindolylmethane
2 D-limonene
2 Lemongrass Extract/Citral
2 Exercise
2 Flaxseed Oil
2 Shilajit/Fulvic Acid
2 Ginkgo biloba
2 Genistein (soy isoflavone)
2 Geraniol
2 Ginkgolide B
2 Ginseng
2 Spermidine
2 iodine
2 Isoliquiritigenin
2 Recombinant Methioninase
2 Licorice
2 SDG/lignans
2 Lutein
2 Methyl Jasmonate
2 Mangiferin
2 Mushroom Maitake
2 Naringin
2 Niclosamide (Niclocide)
2 Plumbagin
2 Psoralidin
2 Rutin
2 Sesamin
2 Terpinen-4-ol / Tea Tree Oil
1 Gold NanoParticles
1 Photodynamic Therapy
1 Amodiaquine
1 Vitamin A, Retinoic Acid
1 temozolomide
1 Aspirin
1 Aloe anthraquinones
1 epirubicin
1 Lapatinib
1 Ras-selective lethal 3
1 Butyrate
1 urea
1 Centella asiatica / Gotu kola → asiaticoside
1 Vitamin E
1 Cynara scolymus/Globe Artichoke/Artichoke Extract
1 Cyclopamine
1 Deguelin
1 diet Ketogenic
1 Zinc
1 Echinacea
1 Ginkgo biloba-EGb 761
1 Eurycomanone
1 Evodiamine
1 Ferulic acid
1 Fenbendazole
1 Ginkgolic acids
1 Ginger/6-Shogaol/Gingerol
1 γ-linolenic acid (Borage Oil)
1 Graviola
1 hydrogen sulfide
1 Hibiscus sabdariffa
1 HydroxyTyrosol
1 Hyperoside
1 MCT, metronomic chemo
1 Licochalcone A
1 Lactoferrin/Talactoferrin
1 Bevacizumab (brand Avastin)
1 Dordaviprone; Modeyso
1 Modified Citrus Pectin
1 vp16, etoposide
1 Magnetic Field Rotating
1 Methylglyoxal
1 Moringa oleifera
1 Lemon Balm/Melissa officinalis
1 Mucuna pruriens/Velvet Bean
1 Mistletoe/Viscum album Extracts
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Reishi
1 Nimbolide
1 nelfinavir/Viracept
1 Proanthocyanidins
1 SonoDynamic Therapy UltraSound
1 Propyl gallate
1 Ramucirumab (CYRAMZA)
1 Rhein
1 buckwheat sprouts
1 Sulfasalazine
1 irinotecan
1 Lignans
1 cetuximab
1 Aflavin-3,3′-digallate
1 Vitamin D3
1 Vitexin
1 Wogonin
1 Zerumbone
1 Zyflamend
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1106  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page